8-KFiled Aug 10, 8:00 PM ET
Syra Health Corp Reports Q2 2026 Financial Results
$SYRA · Syra Health CorpResearch Summary
AI-generated summary of this SEC filing
Syra Health Corp Reports Q2 2026 Financial Results
What Happened
- Syra Health Corp (SYRA) announced its financial results for the second quarter ended June 30, 2026. The company issued a press release on August 11, 2026 reporting those results, which is furnished as Exhibit 99.1 to the Form 8-K. The 8-K was filed under Item 2.02 (Results of Operations and Financial Condition).
Key Details
- Date of press release: August 11, 2026.
- Reporting period: Quarter ended June 30, 2026.
- Press release furnished as Exhibit 99.1 to the Form 8-K (not “filed” for Section 18 liability purposes).
- The exhibit includes forward-looking statements and the customary cautionary language about those statements.
Why It Matters
- This filing is the company’s official quarterly update to investors on earnings and financial condition for Q2 2026. Investors should review the furnished press release for the specific figures (revenue, profit/loss, cash position and guidance) and note that the release contains forward-looking statements.
- Because the release is furnished rather than filed, it is not automatically subject to certain Exchange Act liabilities and is not incorporated by reference into other filings unless explicitly stated.